Fact check
“The DEA has the authority to reclassify drugs in consultation with the Department of Health and Human Services (HHS).”
Reasoning
The excerpt from the Reason.com article cites the Controlled Substances Act and notes that the DEA, when reclassifying drugs, does so in consultation with the Department of Health and Human Services. This directly confirms the claim.
On confidence: The provided source explicitly states that the DEA has the authority to reclassify drugs in consultation with HHS.
Important context
The authority is derived from the Controlled Substances Act, which assigns the DEA the role of scheduling drugs, with HHS providing medical and scientific input during reclassification decisions.
Evidence
Supporting (1)
- Tier 1 — Primary sourceFederal drug scheduling relies on vague criteria, GAO report finds
cannabis illustrates that puzzle. When Congress enacted the CSA in 1970, it placed marijuana in Schedule I, and the Drug Enforcement Administration (DEA), which had the authority to reclassify drugs in consultation with the Department of…
Limitations
The evidence is limited to a single secondary source summarizing the statutory framework; no primary legal text is provided, but the source reliably reflects the established process. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 1, 2026, 4:49 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Hazy Drug Classification Criteria Invite Dubious Bureaucratic JudgmentsReason · Jacob Sullum